477 results on '"BRILOT, FABIENNE"'
Search Results
2. Infection and Vaccine Induced Spike Antibody Responses Against SARS-CoV-2 Variants of Concern in COVID-19-Naïve Children and Adults
3. Success without intervention: keeping the conversation open
4. Origins and immunopathogenesis of autoimmune central nervous system disorders
5. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
6. Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19
7. Oral corticosteroid dosage and tapeduration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse
8. Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
9. Emerging evidence of Toll-like receptors as a putative pathway linking maternal inflammation and neurodevelopmental disorders in human offspring: A systematic review
10. Cerebrospinal fluid free light chain quantitation is a specific biomarker for inflammatory neurological disorders in a paediatric patient cohort
11. Myelin-oligodendrocyte glycoprotein antibody-associated disease
12. Maternal autoimmunity and inflammation are associated with childhood tics and obsessive-compulsive disorder: Transcriptomic data show common enriched innate immune pathways
13. Single-cell approaches to investigate B cells and antibodies in autoimmune neurological disorders
14. The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease
15. Cross-Sectional and Longitudinal Genotype to Phenotype Surveillance of SARS-CoV-2 Variants Over the First Four Years of the COVID-19 Pandemic
16. International MOGAD criteria
17. A longitudinal analysis of brain volume changes in myelin oligodendrocyte glycoprotein antibody‐associated disease
18. The clinical profile of NMOSD in Australia and New Zealand
19. Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review
20. TMPRSS2 activation of Omicron lineage Spike glycoproteins is regulated by TMPRSS2 cleavage of ACE2
21. 8 Dosing of oral corticosteroid therapy and the risk of relapse at the onset of MOGAD
22. 6 Spike antibody seroconversion and emerging variant cross-reactivity following COVID-19 third vaccination dose in Australian people with multiple Sclerosis
23. Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders
24. Development of Innate CD4+ α-Chain Variable Gene Segment 24 (Vα24) Natural Killer T Cells in the Early Human Fetal Thymus Is Regulated by IL-7
25. A longitudinal analysis of brain volume changes in myelin oligodendrocyte glycoprotein antibody‐associated disease.
26. International multicenter examination of MOG antibody assays
27. SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
28. Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level
29. Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF
30. Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
31. Immune response to COVID‐19 vaccination in patients with Waldenström macroglobulinaemia who pause their BTKi therapy.
32. Humoral signatures of MOG-antibody-associated disease track with age and disease activity
33. Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sublineages in the face of maturing antibody breadth at the population level
34. Infection and vaccine induced Spike antibody responses against SARS-CoV-2 Variants of concern in immune naïve children and adults
35. Targeting B cell dysregulation with emerging therapies in autoimmune demyelinating disorders
36. MOGAD Scoping Review
37. 2432 Spike antibody seroconversion and breadth following SARS-CoV-2 vaccination in Australian people with Multiple Sclerosis
38. Autoimmune encephalitis: Recent updates and emerging challenges
39. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
40. Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti‐spike neutralizing IgG to SARS‐CoV ‐2 variants, but preserved antigen‐specific T cell responses
41. Autoantibodies against aquaporin-4 and myelin oligodendrocyte glycoprotein in paediatric CNS demyelination: Recent developments and future directions
42. Clonal dynamics of SARS-CoV-2-specific T cells in children and adults with COVID-19
43. sj-docx-2-mso-10.1177_20552173211063126 - Supplemental material for Structural and functional markers of optic nerve damage in myelin oligodendrocyte glycoprotein antibody-associated optic neuritis
44. Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti‐spike neutralizing IgG to SARS‐CoV‐2 variants, but preserved antigen‐specific T cell responses
45. sj-docx-1-mso-10.1177_20552173211063126 - Supplemental material for Structural and functional markers of optic nerve damage in myelin oligodendrocyte glycoprotein antibody-associated optic neuritis
46. SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
47. Emergence and Antibody Evasion of BQ and BA.2.75 SARS-CoV-2 Sublineages in the Face of Maturing Antibody Breadth at the Population Level
48. SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
49. Reply to “Investigating the immunopathogenic mechanisms underlying MOGAD ”
50. Efficacy of Vaccine BNT162b2 (Pfizer-BioNTech) in Individuals with Waldenstrom's Macroglobulinemia and Follicular Lymphoma in Australia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.